ANALGESIC USE, BLOOD DYSCRASIAS, AND CASE-CONTROL PHARMACOEPIDEMIOLOGY - A CRITIQUE OF THE INTERNATIONAL AGRANULOCYTOSIS AND APLASTIC-ANEMIA STUDY

被引：36

作者：

KRAMER, MS

LANE, DA

HUTCHINSON, TA

机构：

[1] MCGILL UNIV,FAC MED,DEPT EPIDEMIOL & BIOSTAT,MONTREAL H3A 2T5,QUEBEC,CANADA

[2] MCGILL UNIV,FAC MED,DEPT PEDIAT,MONTREAL H3A 2T5,QUEBEC,CANADA

[3] MCGILL UNIV,FAC MED,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA

[4] UNIV MINNESOTA,SCH STAT,DEPT THEORET STAT,MINNEAPOLIS,MN 55455

来源：

JOURNAL OF CHRONIC DISEASES | 1987年 / 40卷 / 12期

关键词：

D O I：

10.1016/0021-9681(87)90073-7

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：1073 / 1081

页数：9

共 15 条

[1] DRUG-INDUCED BLOOD DYSCRASIAS IN SWEDEN [J].

BOTTIGER, LE ;

WESTERHOLM, B .

BMJ-BRITISH MEDICAL JOURNAL, 1973, 3 (5875) :339-343

[2] HUMORAL SUPPRESSION OF ERYTHROPOIESIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) AND RHEUMATOID-ARTHRITIS [J].

DAINIAK, N ;

HARDIN, J ;

FLOYD, V ;

CALLAHAN, M ;

HOFFMAN, R .

AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :537-544

[3]

DANCEY JT, 1979, BRIT J HAEMATOL, V43, P607, DOI 10.1111/j.1365-2141.1979.tb03793.x

[4] RETARDATION OF COLONY GROWTH OF INVITRO BONE-MARROW CULTURE USING SERA FROM PATIENTS WITH FELTYS SYNDROME, DISSEMINATED LUPUS-ERYTHEMATOSUS (SLE), RHEUMATOID-ARTHRITIS, AND OTHER DISEASE STATES [J].

DUCKHAM, DJ ;

RHYNE, RL ;

SMITH, FE ;

WILLIAMS, RC .

ARTHRITIS AND RHEUMATISM, 1975, 18 (04) :323-333

[5]

FAICH GA, 1986, JAMA-J AM MED ASSOC, V256, P1788

[6]

INMAN MHW, 1977, BR MED J, V6, P1500

[7] PROSPECTIVE VERSUS RETROSPECTIVE APPROACH IN SEARCH FOR ENVIRONMENTAL CAUSES OF MALFORMATIONS [J].

KLEMETTI, A ;

SAXEN, L .

AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1967, 57 (12) :2071-+

[8] THE NOTION OF ACCEPTABLE RISK - THE ROLE OF UTILITY IN DRUG MANAGEMENT [J].

LANE, DA ;

HUTCHINSON, TA .

JOURNAL OF CHRONIC DISEASES, 1987, 40 (06) :621-625

[9]

Miettinen O S, 1983, Stat Med, V2, P267, DOI 10.1002/sim.4780020222

[10]

MIETTINEN OS, 1985, J CHRON DIS, V38, P543, DOI 10.1016/0021-9681(85)90039-6

← 1 2 →